Literature DB >> 26655238

Cell-cell contact promotes Ebola virus GP-mediated infection.

Chunhui Miao1, Minghua Li1, Yi-Min Zheng1, Fredric S Cohen2, Shan-Lu Liu3.   

Abstract

Ebola virus (EBOV) is a highly pathogenic filovirus that causes hemorrhagic fever in humans and animals. Here we provide evidence that cell-cell contact promotes infection mediated by the glycoprotein (GP) of EBOV. Interestingly, expression of EBOV GP alone, even in the absence of retroviral Gag-Pol, is sufficient to transfer a retroviral vector encoding Tet-off from cell to cell. Cell-to-cell infection mediated by EBOV GP is blocked by inhibitors of actin polymerization, but appears to be less sensitive to KZ52 neutralization. Treatment of co-cultured cells with cathepsin B/L inhibitors, or an entry inhibitor 3.47 that targets the receptor NPC1 for virus binding, also blocks cell-to-cell infection. Cell-cell contact also enhances spread of rVSV bearing GP in monocytes and macrophages, the primary targets of natural EBOV infection. Altogether, our study reveals that cell-cell contact promotes EBOV GP-mediated infection, and provides new insight into understanding EBOV spread and viral pathogenesis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell-to-cell infection; Ebola virus; GP

Mesh:

Substances:

Year:  2015        PMID: 26655238      PMCID: PMC4744524          DOI: 10.1016/j.virol.2015.11.019

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  56 in total

1.  Functional importance of the coiled-coil of the Ebola virus glycoprotein.

Authors:  S Watanabe; A Takada; T Watanabe; H Ito; H Kida; Y Kawaoka
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence.

Authors:  Graham Simmons; Rouven J Wool-Lewis; Frédéric Baribaud; Robert C Netter; Paul Bates
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

3.  Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody.

Authors:  Paul W H I Parren; Tom W Geisbert; Toshiaki Maruyama; Peter B Jahrling; Dennis R Burton
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

4.  C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans.

Authors:  Carmen P Alvarez; Fátima Lasala; Jaime Carrillo; Oscar Muñiz; Angel L Corbí; Rafael Delgado
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

5.  Influenza A virus uses intercellular connections to spread to neighboring cells.

Authors:  Kari L Roberts; Balaji Manicassamy; Robert A Lamb
Journal:  J Virol       Date:  2014-11-26       Impact factor: 5.103

6.  Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner.

Authors:  Asuka Nanbo; Masaki Imai; Shinji Watanabe; Takeshi Noda; Kei Takahashi; Gabriele Neumann; Peter Halfmann; Yoshihiro Kawaoka
Journal:  PLoS Pathog       Date:  2010-09-23       Impact factor: 6.823

7.  Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR.

Authors:  George Lin; Graham Simmons; Stefan Pöhlmann; Frédéric Baribaud; Houping Ni; George J Leslie; Beth S Haggarty; Paul Bates; Drew Weissman; James A Hoxie; Robert W Doms
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

8.  Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission.

Authors:  Claire L Brimacombe; Joe Grove; Luke W Meredith; Ke Hu; Andrew J Syder; Maria Victoria Flores; Jennifer M Timpe; Sophie E Krieger; Thomas F Baumert; Timothy L Tellinghuisen; Flossie Wong-Staal; Peter Balfe; Jane A McKeating
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

Review 9.  Exosomes: Implications in HIV-1 Pathogenesis.

Authors:  Marisa N Madison; Chioma M Okeoma
Journal:  Viruses       Date:  2015-07-20       Impact factor: 5.048

10.  Ebolavirus in West Africa, and the use of experimental therapies or vaccines.

Authors:  Thomas Hoenen; Heinz Feldmann
Journal:  BMC Biol       Date:  2014-09-26       Impact factor: 7.431

View more
  4 in total

1.  Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap.

Authors:  Philipp A Ilinykh; Rodrigo I Santos; Bronwyn M Gunn; Natalia A Kuzmina; Xiaoli Shen; Kai Huang; Pavlo Gilchuk; Andrew I Flyak; Patrick Younan; Galit Alter; James E Crowe; Alexander Bukreyev
Journal:  PLoS Pathog       Date:  2018-08-23       Impact factor: 6.823

2.  SARS-CoV-2 spreads through cell-to-cell transmission.

Authors:  Cong Zeng; John P Evans; Tiffany King; Yi-Min Zheng; Eugene M Oltz; Sean P J Whelan; Linda J Saif; Mark E Peeples; Shan-Lu Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-04       Impact factor: 11.205

3.  SARS-CoV-2 Spreads through Cell-to-Cell Transmission.

Authors:  Cong Zeng; John P Evans; Tiffany King; Yi-Min Zheng; Eugene M Oltz; Sean P J Whelan; Linda Saif; Mark E Peeples; Shan-Lu Liu
Journal:  bioRxiv       Date:  2021-06-01

Review 4.  The lifecycle of the Ebola virus in host cells.

Authors:  Dong-Shan Yu; Tian-Hao Weng; Xiao-Xin Wu; Frederick X C Wang; Xiang-Yun Lu; Hai-Bo Wu; Nan-Ping Wu; Lan-Juan Li; Hang-Ping Yao
Journal:  Oncotarget       Date:  2017-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.